Vanda Historical Income Statement
| VNDA Stock | USD 5.19 0.21 4.22% |
Historical analysis of Vanda Pharmaceuticals income statement accounts such as Depreciation And Amortization of 2.9 M, Interest Expense of 6 M, Total Revenue of 137 M or Gross Profit of 123.7 M can show how well Vanda Pharmaceuticals performed in making a profits. Evaluating Vanda Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Vanda Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Vanda Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vanda Pharmaceuticals is a good buy for the upcoming year.
Vanda |
About Vanda Income Statement Analysis
Vanda Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Vanda Pharmaceuticals shareholders. The income statement also shows Vanda investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Vanda Pharmaceuticals Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Vanda Pharmaceuticals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Vanda Pharmaceuticals minus its cost of goods sold. It is profit before Vanda Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Vanda Pharmaceuticals. It is also known as Vanda Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Vanda Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Vanda Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vanda Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Vanda Stock refer to our How to Trade Vanda Stock guide.At present, Vanda Pharmaceuticals' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Cost Of Revenue is expected to grow to about 19.7 M, whereas Depreciation And Amortization is forecasted to decline to about 2.9 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 243.1M | 230.1M | 192.6M | 123.7M | Total Revenue | 268.7M | 254.4M | 192.6M | 137.0M |
Vanda Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Vanda Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vanda Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 1.5M | 2.9M | 2.8M | 2.7M | 3.0M | 2.9M | |
| Interest Expense | 6.2M | 4.4M | 199K | 5.0M | 5.7M | 6.0M | |
| Total Revenue | 227.2M | 248.2M | 268.7M | 254.4M | 192.6M | 137.0M | |
| Gross Profit | 202.7M | 224.8M | 243.1M | 230.1M | 192.6M | 123.7M | |
| Other Operating Expenses | 204.4M | 220.9M | 226.5M | 248.1M | 206.6M | 128.7M | |
| Operating Income | 22.8M | 27.2M | 42.2M | 6.3M | (14.0M) | (14.6M) | |
| Ebit | 22.8M | 27.2M | 42.2M | 6.3M | (14.0M) | (14.6M) | |
| Research Development | 48.6M | 55.6M | 75.4M | 85.8M | 76.8M | 42.8M | |
| Ebitda | 24.3M | 30.1M | 45.0M | 9.1M | (14.0M) | (14.6M) | |
| Cost Of Revenue | 24.5M | 23.4M | 25.6M | 24.3M | 17.6M | 19.7M | |
| Total Operating Expenses | 179.9M | 197.6M | 200.9M | 223.8M | 206.6M | 118.0M | |
| Income Before Tax | 29.0M | 31.7M | 42.4M | 11.3M | 6.3M | 6.7M | |
| Total Other Income Expense Net | 6.2M | 4.4M | 199K | 5.0M | 20.3M | 21.3M | |
| Net Income | 115.6M | 23.3M | 33.2M | 6.3M | 2.5M | 2.6M | |
| Income Tax Expense | (86.5M) | 8.3M | 9.2M | 5.0M | 3.8M | 4.0M | |
| Selling General Administrative | 126.5M | 127.9M | 117.3M | 133.9M | 122.1M | 75.8M | |
| Net Income Applicable To Common Shares | 115.6M | 23.3M | 33.2M | 6.3M | 7.2M | 8.4M | |
| Net Income From Continuing Ops | 115.6M | 23.3M | 33.2M | 6.3M | 11.8M | 8.8M | |
| Tax Provision | (86.5M) | 8.3M | 9.2M | 5.0M | 5.8M | 6.1M | |
| Reconciled Depreciation | 2.9M | 2.9M | 2.8M | 2.7M | 2.5M | 2.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vanda Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vanda Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vanda Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vanda Pharmaceuticals Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vanda Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Vanda Stock refer to our How to Trade Vanda Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vanda Pharmaceuticals. If investors know Vanda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vanda Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (0.19) | Revenue Per Share 3.293 | Quarterly Revenue Growth 0.228 | Return On Assets (0.04) |
The market value of Vanda Pharmaceuticals is measured differently than its book value, which is the value of Vanda that is recorded on the company's balance sheet. Investors also form their own opinion of Vanda Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vanda Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vanda Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vanda Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vanda Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vanda Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vanda Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.